Prof Michael Schneider

Professor Schneider's research addresses cardiac muscle cell number as a therapeutic target, and the development of innovative approaches to cardiac regeneration and repair. Current projects are focused on PDGF Receptor alpha-positive cardiac stem cells (Nature Communications, 2015), and on MAP kinase kinase kinase kinase-4 (MAP4K4; Nature Communications, 2014).